Double-blind, placebo-controlled randomised clinical trial to evaluate the effect of ASPIRIN discontinuation after left atrial appendage occlusion in atrial fibrillation: protocol of the ASPIRIN LAAO trial
Introduction It is the common clinical practice to prescribe indefinite aspirin for patients with non-valvular atrial fibrillation (NVAF) post left atrial appendage occlusion (LAAO). However, aspirin as a primary prevention strategy for cardiovascular diseases has recently been challenged due to inc...
Main Authors: | Xiaochen Wang, Yansong Li, Bin Yang, Jian Sun, Mu Chen, Qunshan Wang, Peng-Pai Zhang, Bin-Feng Mo, Tai-Zhong Chen, Xiaoli Tang, Yi-Gang Li, Jian-An Wang, An-Li Tang; Hao Hu, Si-Ming Tao, Qi Lu, Zongjun Liu, Zhaohui Qiu, Chun Gui |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-03-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/3/e044695.full |
Similar Items
-
Effectiveness of intranasal lysine-aspirin in patients with aspirin-sensitive, and aspirin tolerant nasal polyposis : controlled trials
by: Parikh, A. A.
Published: (2007) -
Atrial Premature Contractions Arising from the Right Atrial Appendage
by: Xiang-Fei Feng, et al.
Published: (2017-01-01) -
Combined Therapy of Catheter Ablation and Left Atrial Appendage Closure for Patients with Atrial Fibrillation: A Case-Control Study
by: Bin-Feng Mo, et al.
Published: (2020-01-01) -
Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial
by: Chan-Hyuk Lee, et al.
Published: (2019-05-01) -
TRIAL OF ASPIRIN AND CALCIUM ON PREVENTION OF PREECLAMPSIA
by: ALI AKBA TAHERIAN, et al.
Published: (2002-06-01)